Expected discontinuation symptoms of the contraceptive pill: How effective is expectation-optimizing message framing?
Not Applicable
Recruiting
- Conditions
- Current users of the contraceptive pill
- Registration Number
- DRKS00032645
- Lead Sponsor
- Philipps-Universität Marburg, Fachbereich Psychologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Current use of the contraceptive pill
Informed consent for participation in the study
fluent in German language
no or correctable visual or hearing impairment
Exclusion Criteria
Not meeting inclusion criteria
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of expected discontinuation symptoms of the contraceptive pill via an adaption of the Generic Assessment of Side Effects Questionnaire (GASE)<br>Points of measurement: prior to video presentation (Baseline), directly post video presentation (T1), 24 hours post video presentation (T2), 1 week post video presentation (T3)
- Secondary Outcome Measures
Name Time Method Assessment of the burden of potential discontinuation symptoms (4-point Likert scale) at basline, T1, T2, T3<br>Assessment of discontinuation intentions (VAS, adaption of the Stages of Change Measurement) at baseline, T1, T2, T3<br><br>Potential moderators (at baseline):<br>Perceived Sensitivity to Medication (PSM)<br>Beliefs About Medicines Questionnaire (BMQ)<br>(State) Trait Anxiety Inventory (STAI)<br>Sosciodemographic data (e.g., age, marital status, reason for intake)